​

Phathom Pharmaceuticals (PHAT) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Phathom Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$55.25M

Latest Revenue (Q)

$28.52M

Phathom Pharmaceuticals Revenue by Period

Phathom Pharmaceuticals Revenue by Year

DateRevenueChange
2024-12-31$55.25M8001.47%
2023-12-31$682.00K100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31--

Phathom Pharmaceuticals generated $55.25M in revenue during NA 2024, up 8001.47% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Phathom Pharmaceuticals Revenue by Quarter

DateRevenueChange
2025-03-31$28.52M-3.86%
2024-12-31$29.66M81.41%
2024-09-30$16.35M123.27%
2024-06-30$7.32M283.05%
2024-03-31$1.91M180.35%
2023-12-31$682.00K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31--

Phathom Pharmaceuticals generated $28.52M in revenue during Q1 2025, up -3.86% compared to the previous quarter, and up 4181.67% compared to the same period a year ago.

Phathom Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
BPMCBlueprint Medicines$508.82M$149.41M
KNSAKiniksa Pharmaceuticals$423.24M$137.78M
DAWNDay One Biopharmaceuticals$131.16M$29.21M
AMLXAmylyx Pharmaceuticals$87.37M$-665.00K
PHATPhathom Pharmaceuticals$55.25M$28.52M
XFORX4 Pharmaceuticals$2.56M$28.81M
LYRALyra Therapeutics$1.53M$209.00K
CGEMCullinan Oncology--
GPCRStructure Therapeutics--
IMMXImmix Biopharma--
CNSPCNS Pharmaceuticals--
HEPAHepion Pharmaceuticals--
ABOSAcumen Pharmaceuticals--
INZYInozyme Pharma--
TERNTerns Pharmaceuticals--

PHAT Revenue FAQ

What is Phathom Pharmaceuticals’s yearly revenue?

Phathom Pharmaceuticals's yearly revenue for 2024 was $55.25M, representing an increase of 8001.47% compared to 2023. The company's yearly revenue for 2023 was $682K, representing an increase of 100.00% compared to 2022. PHAT's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Phathom Pharmaceuticals’s quarterly revenue?

Phathom Pharmaceuticals's quarterly revenue for Q1 2025 was $28.52M, a -3.86% decrease from the previous quarter (Q4 2024), and a 1391.58% increase year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $29.66M, a 81.41% increase from the previous quarter (Q3 2024), and a 4249.56% increase year-over-year (Q4 2023). PHAT's quarterly revenue for Q3 2024 was $16.35M, a 123.27% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023).

What is Phathom Pharmaceuticals’s revenue growth rate?

Phathom Pharmaceuticals's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.